2/1/2012 9:57 AM 

"Another mega deal hangs in the balance amid regulatory scrutiny.  Pharmacy benefit managers Express Scripts Inc. and Medco Health Solutions Inc. are awaiting word from the FTC on their $29 billion merger, which has faced criticism from consumer groups that the deal will increase drug costs."

- Gina Chon, "Global Regulators Proving Hard To Please On Mergers," The Wall Street Journal's "Deal Journal," February 1, 2012